Suchergebnisse - "Simpson, Iain"

PubPharm (249)

61

2020 ESC Guidelines for the management of adult congenital heart disease

enthalten in: European heart journal | 2021

von Baumgartner, H. | De Backer, J. | Babu-Narayan, S. | +110

CommentIn: Rev Esp Cardiol (Engl Ed). 2021 May;74(5):371-377. - PMID 33771487

62

AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib

enthalten in: Molecular cancer therapeutics | 2021

von Flemington, V. | Davies, E. | Robinson, D. | +27

63

ARGINASE INHIBITORS AND METHODS OF USE THEREOF

enthalten in: Europäisches Patentamt | 2021

von MLYNARSKI SCOTT NATHAN | SHIELDS JASON | KAWATKAR SAMEER | +5

64

ARGINASE INHIBITORS AND METHODS OF USE THEREOF

enthalten in: Europäisches Patentamt | 2021

von MLYNARSKI SCOTT NATHAN | SHIELDS JASON | KAWATKAR SAMEER | +5

65

Industry news update covering June 2021

enthalten in: Therapeutic Delivery | 2021

von Simpson, I.

66

Industry Update covering November 2020

enthalten in: Therapeutic Delivery | 2021

von Simpson, I.

67

Industry update covering January 2021

enthalten in: Therapeutic Delivery | 2021

von Simpson, I.

68

ARGINASE INHIBITORS AND METHODS OF USE THEREOF

enthalten in: Europäisches Patentamt | 2020

von MLYNARSKI SCOTT NATHAN | GREBE TYLER | KAWATKAR SAMEER | +5

69

ARGINASE INHIBITORS AND METHODS OF USE THEREOF

enthalten in: Europäisches Patentamt | 2020

von MLYNARSKI SCOTT NATHAN | GREBE TYLER | KAWATKAR SAMEER | +5

70

Therapeutic delivery : industry update covering June 2020

enthalten in: Therapeutic delivery | 2020

von Simpson, I.